These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 29849166

  • 1. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT.
    Sci Rep; 2018 May 30; 8(1):8367. PubMed ID: 29849166
    [Abstract] [Full Text] [Related]

  • 2. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N, Bilen Ş, Topçu Yılmaz P, Evren Kemer Ö.
    Int Ophthalmol; 2022 Aug 30; 42(8):2625-2632. PubMed ID: 35355169
    [Abstract] [Full Text] [Related]

  • 3. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P, Choolam A, Kulkantrakorn K.
    Neurol Sci; 2017 Nov 30; 38(11):2031-2036. PubMed ID: 28884242
    [Abstract] [Full Text] [Related]

  • 4. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug 30; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 5. Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Alexandru H, Muthuraman M, Chirumamilla VC, Koirala N, Paktas B, Deuschl G, Zeuner KE, Groppa S.
    PLoS One; 2016 Aug 30; 11(12):e0168652. PubMed ID: 27992533
    [Abstract] [Full Text] [Related]

  • 6. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS, MacKenzie KR, Cook AE, Leatherbarrow B.
    Clin Exp Ophthalmol; 2010 Oct 30; 38(7):688-91. PubMed ID: 20456439
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
    Ferrazzano G, Conte A, Fabbrini G, Bologna M, Macerollo A, Defazio G, Hallett M, Berardelli A.
    J Neurol Neurosurg Psychiatry; 2015 Mar 30; 86(3):336-40. PubMed ID: 24963123
    [Abstract] [Full Text] [Related]

  • 8. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI, Shin HM, Lee SY, Lew H.
    Acta Ophthalmol; 2013 Mar 30; 91(2):e108-12. PubMed ID: 23425111
    [Abstract] [Full Text] [Related]

  • 9. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q.
    Am J Ophthalmol; 2014 Mar 30; 157(3):591-7.e1-2. PubMed ID: 24269849
    [Abstract] [Full Text] [Related]

  • 10. Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm.
    Zhou Y, Wang W, Lin Z, Lin T, Gong L.
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec 30; 261(12):3615-3623. PubMed ID: 37341835
    [Abstract] [Full Text] [Related]

  • 11. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr 30; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 12. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC, Oliveira GC, Cariello AJ, Felberg S, Osaki MH.
    Arq Bras Oftalmol; 2010 Apr 30; 73(5):405-8. PubMed ID: 21225122
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr 30; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 14. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M, Schiavi C, Taroni L, Sebastiani S, Bernabei F, Roda M, Moscardelli F, Giannaccare G.
    Indian J Ophthalmol; 2019 Sep 30; 67(9):1405-1409. PubMed ID: 31436182
    [Abstract] [Full Text] [Related]

  • 15. Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication.
    Wenninger FC, Wabbels B.
    Toxins (Basel); 2022 Nov 07; 14(11):. PubMed ID: 36356019
    [Abstract] [Full Text] [Related]

  • 16. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Nov 07; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 17. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Nov 07; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 18. Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm.
    Mali YP, Schultze RL, Wladis EJ.
    Orbit; 2017 Oct 07; 36(5):307-310. PubMed ID: 28627956
    [Abstract] [Full Text] [Related]

  • 19. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L, Pan Y, Zhang X, Hu Y, Cai L, Nie Z, Pan L, Li B, He Y, Jin L.
    Neurol Sci; 2016 Nov 07; 37(11):1807-1813. PubMed ID: 27431279
    [Abstract] [Full Text] [Related]

  • 20. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP.
    Arq Bras Oftalmol; 2006 Nov 07; 69(1):23-6. PubMed ID: 16491229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.